Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program

Cad Saude Publica. 2012 Sep;28(9):1623-31. doi: 10.1590/s0102-311x2012000900002.

Abstract

In this study, the frequency of detected congenital hypothyroidism, phenylketonuria and haemoglobinopathies in the State of Rio de Janeiro's (Brazil) Newborn Screening Program (NBSP) was analyzed between the years of 2005 and 2007. There were two Newborn Screening Reference Centers (named NSRC A and B) with programmatic differences. In 2007, overall detection coverage reached 80.7%. The increase in the incidence of congenital hypothyroidism (1:1,030 in 2007) was attributed to the reduction of neonatal TSH value limits over time. The incidence discrepancy of phenylketonuria between NSRC A (1:28,427) and B (1:16,522) might be partially explained by the small number of cases. The incidence of sickle cell disease and its traits were uniformly high (1:1,288 and 1:21, respectively). This was coherent with the ethnic composition of the population. The differences in laboratory methods and critical values, in addition to other programmatic issues, may explain the variances in the results and limited analysis of the role of biological and environmental determinants in the occurrence of these diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil / epidemiology
  • Congenital Hypothyroidism / diagnosis
  • Congenital Hypothyroidism / epidemiology*
  • Hemoglobinopathies / diagnosis
  • Hemoglobinopathies / epidemiology*
  • Humans
  • Incidence
  • Infant, Newborn
  • Neonatal Screening*
  • Phenylketonurias / diagnosis
  • Phenylketonurias / epidemiology*
  • Rare Diseases / diagnosis
  • Rare Diseases / epidemiology
  • Retrospective Studies